Fig. 4
From: BCL7A as a novel prognostic biomarker for glioma patients
Low BCL7A expression associated with IDH wildtype and 1p19q codeletion. There were 48 LGG tissues and 36 GBM tissues conducted for IDH and 1p19q status testing in our cohort. A, B BCL7A gene differentially expressed in different IDH and 1p19q status was detected by IHC. Represented images of IHC staining of BCL7A were presented. C, D. Expression of BCL7A in different IDH1/2 and 1p19q status of glioma in TCGA and CCGA datasets. All data were downloaded from Gliovis. IDH, isocitrate dehydrogenase. WT, wildtype. Mut, mutant. *, p < 0.05. **, p < 0.01. ***, p < 0.001. ns, no significance